• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human Fibrinogen alpha chain (FGA) Polyclonal Antibody

The antibody against Fibrinogen alpha chain (FGA) was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 410-559 of human Fibrinogen alpha chain (FGA) (NP_000499.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IHC-P, ELISA.

ADA-10204A

The antibody against Fibrinogen alpha chain (FGA) was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 410-559 of human Fibrinogen alpha chain (FGA) (NP_000499.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IHC-P, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-10204A ClonalityPolyclonal
Host SpeciesRabbitTarget NameFibrinogen alpha chain (FGA)
Target SynonymsFib2; Fibrinogen alpha chain (FGA)FormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesHepG2, Mouse liver, Rat liverApplicationELISA, WB, IHC-P

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 410-559 of human Fibrinogen alpha chain (FGA) (NP_000499.1).Target SpeciesHuman
Immunogen SequenceWGTFEEVSGNVSPGTRREYHTEKLVTSKGDKELRTGKEKVTSGSTTTTRRSCSKTVTKTVIGPDGHKEVTKEVVTSEDGSDCPEAMDLGTLSGIGTLDGFRHRHPDEAAFFDTASTGKTFPGFFSPMLGEFVSETESRGSESGIFTNTKEUniprot IDP02671

Inquire Rabbit anti-Human Fibrinogen alpha chain (FGA) Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification